Back to Agenda
Session 6, Track B: Challenges, Opportunities, and Best Practices in Pharmacovigilance in the LATAM (Part II)
Session Chair(s)
Raphael Elmadjian Pareschi, PHARMD, MBA
Patient Safety Lead/ Head of Pharmacovigilance Brazil, Roche, Brazil
Rosana M. Mastellaro, PHARMD, RPH
Director, Technical Regulatory Affairs and Innovation, Sindusfarma, Brazil
Continuing as Part II, this session focuses on strengthening pharmacovigilance in LATAM through Regional and local perspectives. Examine current challenges arising from diverse regulations, identify practical opportunities for regional collaboration (regulators, HCPs, industry), and learn from best practices showcased from successful LATAM initiatives to enhance local PV effectiveness.
Learning Objective : - Identify key challenges due to diverse regulations and local operations
-
Describe collaboration opportunities among stakeholders (regulatory bodies, HCPs, industry) within LATAM to strengthen PV systems
- Recognize successful best practices and strategies implemented within Latin America that have demonstrably enhanced local or regional pharmacovigilance effectiveness
Speaker(s)
Challenges, Opportunities, and Best Practices in Pharmacovigilance in LATAM
Colombia PSL & PV Policy Lead Latam , Roche, Colombia
Challenges, Opportunities, and Best Practices in Pharmacovigilance in Latin America
Head of the National Pharmacovigilance Center, Ministry of Health of Costa Rica, Costa Rica
Challenges, Opportunities, and Best Practices in Pharmacovigilance in Latin America
Specialist Health Surveillance - Pharmacovigilance, ANVISA, Brazil
Have an account?